
Brian E. Mcdowell
Examiner (ID: 5411, Phone: (571)270-5755 , Office: P/1624 )
| Most Active Art Unit | 1624 |
| Art Unit(s) | 4161, 1624 |
| Total Applications | 1663 |
| Issued Applications | 1042 |
| Pending Applications | 129 |
| Abandoned Applications | 533 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16885337
[patent_doc_number] => 20210171532
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => Method for Producing 3,6-Disubstituted-Imidazo[1,2-B]Pyridazine Derivative
[patent_app_type] => utility
[patent_app_number] => 17/164684
[patent_app_country] => US
[patent_app_date] => 2021-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3515
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17164684
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/164684 | Method for producing 3,6-disubstituted-imidazo[1,2-b]pyridazine derivative | Jan 31, 2021 | Issued |
Array
(
[id] => 18725689
[patent_doc_number] => 20230339866
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => Quinazoline compounds and the use thereof in the treatment of cancer
[patent_app_type] => utility
[patent_app_number] => 17/795515
[patent_app_country] => US
[patent_app_date] => 2021-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22726
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17795515
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/795515 | Quinazoline compounds and the use thereof in the treatment of cancer | Jan 31, 2021 | Pending |
Array
(
[id] => 18269500
[patent_doc_number] => 20230090742
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => AMINOPYRIMIDINYLAMINOBENZONITRILE DERIVATIVES AS NEK2 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/759147
[patent_app_country] => US
[patent_app_date] => 2021-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24798
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -56
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17759147
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/759147 | AMINOPYRIMIDINYLAMINOBENZONITRILE DERIVATIVES AS NEK2 INHIBITORS | Jan 28, 2021 | Pending |
Array
(
[id] => 18145274
[patent_doc_number] => 20230019129
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => HEPATITIS B CORE PROTEIN ALLOSTERIC MODULATORS
[patent_app_type] => utility
[patent_app_number] => 17/154721
[patent_app_country] => US
[patent_app_date] => 2021-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 88986
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17154721
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/154721 | HEPATITIS B CORE PROTEIN ALLOSTERIC MODULATORS | Jan 20, 2021 | Abandoned |
Array
(
[id] => 18243614
[patent_doc_number] => 20230075925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => NON-PERIPHERAL QUATERNARY AMMONIUM-MODIFIED ZINC PHTHALOCYANINE AND PREPARATION METHOD AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/793297
[patent_app_country] => US
[patent_app_date] => 2021-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4095
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17793297
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/793297 | NON-PERIPHERAL QUATERNARY AMMONIUM-MODIFIED ZINC PHTHALOCYANINE AND PREPARATION METHOD AND USE THEREOF | Jan 14, 2021 | Abandoned |
Array
(
[id] => 18265441
[patent_doc_number] => 20230086683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => PLATELET STORAGE METHODS AND COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/792890
[patent_app_country] => US
[patent_app_date] => 2021-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8678
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17792890
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/792890 | PLATELET STORAGE METHODS AND COMPOSITIONS | Jan 12, 2021 | Pending |
Array
(
[id] => 18384450
[patent_doc_number] => 11655218
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-23
[patent_title] => Crystalline substituted pyrazines as PGI2 receptor agonists
[patent_app_type] => utility
[patent_app_number] => 17/134796
[patent_app_country] => US
[patent_app_date] => 2020-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 5085
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17134796
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/134796 | Crystalline substituted pyrazines as PGI2 receptor agonists | Dec 27, 2020 | Issued |
Array
(
[id] => 17052120
[patent_doc_number] => 20210261554
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => RIPK2 INHIBITORS AND METHOD OF TREATING CANCER WITH SAME
[patent_app_type] => utility
[patent_app_number] => 17/134270
[patent_app_country] => US
[patent_app_date] => 2020-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14145
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17134270
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/134270 | RIPK2 INHIBITORS AND METHOD OF TREATING CANCER WITH SAME | Dec 25, 2020 | Abandoned |
Array
(
[id] => 16991703
[patent_doc_number] => 20210230123
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE
[patent_app_type] => utility
[patent_app_number] => 17/133179
[patent_app_country] => US
[patent_app_date] => 2020-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 64202
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17133179
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/133179 | INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE | Dec 22, 2020 | Abandoned |
Array
(
[id] => 16915715
[patent_doc_number] => 20210188807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => COMPOUNDS ACTIVE TOWARDS NUCLEAR RECEPTORS
[patent_app_type] => utility
[patent_app_number] => 17/126182
[patent_app_country] => US
[patent_app_date] => 2020-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49998
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17126182
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/126182 | Compounds active towards nuclear receptors | Dec 17, 2020 | Issued |
Array
(
[id] => 18282228
[patent_doc_number] => 20230097700
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => AZETIDINE SULFONAMIDE COMPOUND
[patent_app_type] => utility
[patent_app_number] => 17/781918
[patent_app_country] => US
[patent_app_date] => 2020-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29854
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17781918
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/781918 | AZETIDINE SULFONAMIDE COMPOUND | Dec 3, 2020 | Abandoned |
Array
(
[id] => 19608879
[patent_doc_number] => 12157745
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-03
[patent_title] => Heterocyclic systems and pharmaceutical compositions thereof
[patent_app_type] => utility
[patent_app_number] => 17/112088
[patent_app_country] => US
[patent_app_date] => 2020-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 19
[patent_no_of_words] => 12451
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17112088
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/112088 | Heterocyclic systems and pharmaceutical compositions thereof | Dec 3, 2020 | Issued |
Array
(
[id] => 19512020
[patent_doc_number] => 20240343706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-17
[patent_title] => PIPERIDINE-2,6-DIONE DERIVATIVES WHICH BIND TO CEREBLON, AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/780891
[patent_app_country] => US
[patent_app_date] => 2020-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24697
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17780891
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/780891 | PIPERIDINE-2,6-DIONE DERIVATIVES WHICH BIND TO CEREBLON, AND METHODS OF USE THEREOF | Nov 26, 2020 | Pending |
Array
(
[id] => 18268340
[patent_doc_number] => 20230089582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => 1,2,4-TRIAZINE-3,5-DIONE COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/779522
[patent_app_country] => US
[patent_app_date] => 2020-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14055
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17779522
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/779522 | 1,2,4-TRIAZINE-3,5-DIONE COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | Nov 24, 2020 | Pending |
Array
(
[id] => 17214419
[patent_doc_number] => 20210347756
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR
[patent_app_type] => utility
[patent_app_number] => 17/102628
[patent_app_country] => US
[patent_app_date] => 2020-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31114
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17102628
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/102628 | INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR | Nov 23, 2020 | Abandoned |
Array
(
[id] => 18910340
[patent_doc_number] => 11873309
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-16
[patent_title] => Heterocyclic compounds as immunomodulators
[patent_app_type] => utility
[patent_app_number] => 16/952872
[patent_app_country] => US
[patent_app_date] => 2020-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30818
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1974
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16952872
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/952872 | Heterocyclic compounds as immunomodulators | Nov 18, 2020 | Issued |
Array
(
[id] => 18109464
[patent_doc_number] => 20230002344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => NOVEL BENZOTHIOPHENE DERIVATIVES AND USE THEREOF FOR STIMULATING MITOCHONDRIAL TURNOVER
[patent_app_type] => utility
[patent_app_number] => 17/777496
[patent_app_country] => US
[patent_app_date] => 2020-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13881
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17777496
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/777496 | NOVEL BENZOTHIOPHENE DERIVATIVES AND USE THEREOF FOR STIMULATING MITOCHONDRIAL TURNOVER | Nov 17, 2020 | Abandoned |
Array
(
[id] => 16711830
[patent_doc_number] => 20210078977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => NOVEL PYRIMIDINES AS EGFR INHIBITORS AND METHODS OF TREATING DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/950465
[patent_app_country] => US
[patent_app_date] => 2020-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25588
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16950465
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/950465 | Pyrimidines as EGFR inhibitors and methods of treating disorders | Nov 16, 2020 | Issued |
Array
(
[id] => 16885314
[patent_doc_number] => 20210171509
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => MATRIX METALLOPROTEINASE (MMP) INHIBITORS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/097314
[patent_app_country] => US
[patent_app_date] => 2020-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17736
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17097314
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/097314 | Matrix metalloproteinase (MMP) inhibitors and methods of use thereof | Nov 12, 2020 | Issued |
Array
(
[id] => 18612255
[patent_doc_number] => 20230278987
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => Antimicrobial Compounds and Methods
[patent_app_type] => utility
[patent_app_number] => 17/776580
[patent_app_country] => US
[patent_app_date] => 2020-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27222
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17776580
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/776580 | Antimicrobial Compounds and Methods | Nov 11, 2020 | Pending |